NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









biotx.ai GmbH

biotx.ai GmbH

Private
PotsdamHealthcare & Life Scienceshttps://www.biotx.ai/

Last Round

Early Funding

Feb 1, 2023

Total Funding Raised

$2.85M

Company Overview

biotx.ai GmbH is a biotechnology company that provides an AI-driven drug discovery platform using causal modeling and Mendelian randomization to identify therapeutic targets and predict clinical trial outcomes for the biopharma industry.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Clinical Trials, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

causal AIdrug discoverysynthetic clinical trialsgenomic data analysistarget discoveryMendelian randomizationTechBioAI drug discoveryclinical trial predictiongenome-wide association studyGWASprecision medicinein silico trialsdrug development pipelinebiobank data

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

biotx.ai GmbH Comps

Public and private peers based on sector, stage, and business model.

biotx.ai GmbH comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

biotx.ai GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingFeb 1, 2023
GrantMay 31, 2018

Key People

Founding team and executive leadership

Joern Klinger

CEO, Co-CEO & CTO

Executive Team

Marco Schmidt

CEO

Executive Team

Charles Ravarani

Chief Technology Officer

Executive Team

biotx.ai GmbH Investors

Notable investors and investment history

biotx.ai GmbH investors
InvestorRounds
Think.HealthEarly Funding
Peak PrideEarly Funding
European Regional Development Fund (ERDF)Grant
Brandenburg KapitalEarly Funding
SquareOne Venture CapitalEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Monthly visitors increased 186% MoM.

biotx.ai GmbH Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

biotx.ai GmbH Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about biotx.ai GmbH's valuation, stock price, and market status.

Firmographic Details

HeadquartersPotsdam
Employee Range15
Year Founded2017
Last FundingFeb 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.